Literature DB >> 11376311

Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.

J G Webb1, T A Sanborn, L A Sleeper, R G Carere, C E Buller, J N Slater, K W Baran, P T Koller, J D Talley, M Porway, J S Hochman.   

Abstract

BACKGROUND: The SHOCK Registry prospectively enrolled patients with cardiogenic shock complicating acute myocardial infarction in 36 multinational centers.
METHODS: Cardiogenic shock was predominantly attributable to left ventricular pump failure in 884 patients. Of these, 276 underwent percutaneous coronary intervention (PCI) after shock onset and are the subject of this report.
RESULTS: The majority (78%) of patients undergoing angiography had multivessel disease. As the number of diseased arteries rose from 1 to 3, mortality rates rose from 34.2% to 51.2%. Patients who underwent PCI had lower in-hospital mortality rates than did patients treated medically (46.4% vs 78.0%, P < .001), even after adjustment for patient differences and survival bias (P = .037). Before PCI, the culprit artery was occluded (Thrombolysis In Myocardial Infarction grade 0 or 1 flow) in 76.3%. After PCI, the in-hospital mortality rate was 33.3% if reperfusion was complete (grade 3 flow), 50.0% with incomplete reperfusion (grade 2 flow), and 85.7% with absent reperfusion (grade 0 or 1 flow) (P < .001).
CONCLUSIONS: This prospective, multicenter registry of patients with acute myocardial infarction complicated by cardiogenic shock is consistent with a reduction in mortality rates as the result of percutaneous coronary revascularization. Coronary artery patency was an important predictor of outcome. Measures to promote early and rapid reperfusion appear critically important in improving the otherwise poor outcome associated with cardiogenic shock.

Entities:  

Mesh:

Year:  2001        PMID: 11376311     DOI: 10.1067/mhj.2001.115294

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents.

Authors:  Martino Pepe; Massimo Napodano; Giuseppe Tarantini; Chiara Fraccaro; Ada Cutolo; Diletta Peluso; Giambattista Isabella; Angelo Ramondo; Sabino Iliceto
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

2.  Predictors of outcome after percutaneous treatment for cardiogenic shock.

Authors:  A G C Sutton; P Finn; J A Hall; A A Harcombe; R A Wright; M A de Belder
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 3.  [Therapy of cardiogenic shock after myocardial infarction].

Authors:  M Ferrari; H R Figulla
Journal:  Internist (Berl)       Date:  2008-09       Impact factor: 0.743

4.  Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Eun Hui Bae; Sang Yup Lim; Myung Ho Jeong; Hyung Wook Park; Ji Hyun Lim; Young Joon Hong; Weon Kim; Ju Han Kim; Jeong Gwan Cho; Young Keun Ahn; Jong Chun Park; Soon Pal Suh; Byoung Hee Ahn; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

5.  Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial.

Authors:  J R Timmer; I C C van der Horst; J P S Henriques; K Thomas; H J G Bilo; J C A Hoorntje; M J de Boer; H Suryapranata; F Zijlstra
Journal:  Neth Heart J       Date:  2003-10       Impact factor: 2.380

6.  Evolving strategies in the treatment of acute myocardial infarction-induced cardiogenic shock.

Authors:  Vakhtang Tchantchaleishvili; Heidi Schubmehl; Michael F Swartz; William Hallinan; H Todd Massey
Journal:  Ann Cardiothorac Surg       Date:  2014-11

7.  Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock.

Authors:  Mohammed M Abuzahra; Andres Mesa; Bernardo Treistman
Journal:  Tex Heart Inst J       Date:  2007

8.  Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock.

Authors:  Oliver Koeth; Ralf Zahn; Tobias Heer; Timm Bauer; Claus Juenger; Bärbel Klein; Anselm Kai Gitt; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2009-10-25       Impact factor: 5.460

9.  Emergency coronary stenting of unprotected critical left main coronary artery stenosis in acute myocardial infarction and cardiogenic shock.

Authors:  H McArdle; M Bhandari; J Kovac
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 10.  Current Concepts and New Trends in the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction.

Authors:  Theodora Benedek; Dan Dobreanu
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.